EQSNews: Jupiter Wellness, Inc.
Jupiter Wellness’s Potential New OTC Drug Could Put Some More Joy Back Into Breast Cancer Survivors’ Lives
18.10.2022 / 15:09 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
|
|
|
DGAPNews: Jupiter Wellness, Inc.
Jupiter Wellnesss Booster Drug Has Potential To Increase Hair Loss Treatments Efficacy By Enhancing Crucial Enzyme Enrichment Capacity by 7x
13.09.2022 / 14:58 CET/CEST
The issuer is solely responsible for the content of this announcement.
Humans have long had a fascination with hair. From S... Lire le communiqué |
|
|
|
|
DGAPNews: Jupiter Wellness, Inc.
It All Comes Down To Science And Research With The Efficacy Of Jupiter Wellness’s Lineup Of Skin And Hair Treatment Drugs
06.09.2022 / 14:55 CET/CEST
The issuer is solely responsible for the content of this announcement.
Today’s consumers are seemingly more health and wellness cons... Lire le communiqué |
|
|
|
|
DGAPNews: Jupiter Wellness, Inc.
This Company Reports Its Consumer Therapeutics Could Be A Game Changer For People With Skin Problems
25.08.2022 / 21:03 CET/CEST
The issuer is solely responsible for the content of this announcement.
From allergies and insect bites to sunburns and irritations, the human skin can succumb to sev... Lire le communiqué |
|
|
|
|
Data expected Q1 2022 on efficacy of JW200 to clear AK lesions, a common form of precancerous growth that left untreated can lead to cancer in up to 15% of patientsJUPITER, FL / ACCESSWIRE / February 18, 2022 / Jupiter Wellness, Inc. NASDAQ:JUPW today announced it has completed recruitment in its clinical trial of JW200 for the treatment of actinic kera... Lire le communiqué |
|
|
|
|
JUPITER, FL / ACCESSWIRE / February 15, 2022 / Jupiter Wellness, Inc. Nasdaq:JUPW today announced that its merger partner Next Frontier Pharmaceuticals Executive Chairman Shannon Soqui was interviewed on Benzingas All Access 6 Emerging Growth Companies To Watch In 2022 program which can be viewed: HEREJupiter prev... Lire le communiqué |
|
|
|
|
Corporate Presentation Highlights Merged Companys Strength as Leading Drug Developer Focused on Pharma Cannabinoids: LINKJUPITER, FL / ACCESSWIRE / February 2, 2022 / Jupiter Wellness, Inc. NASDAQ:JUPW today announced that its CEO Brian John and Next Frontier Pharmaceuticals Executive Chair... Lire le communiqué |
|
|
|
|